Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

Syndax Pharmaceuticals (Nasdaq: SNDX) will report first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026.

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) will report first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026. Management will host a conference call and live audio webcast at 4:30 p.m. ET.

Access the live audio webcast and slides via the Investors Events & Presentations page or use Conference ID Syndax1Q26 with domestic dial-in 800-590-8290 or international dial-in 240-690-8800. A replay will be posted on the Investors section of the company website approximately 24 hours after the call and will remain available for 90 days.

Argus Apr 24 session

+1.86% close to close 1.1x rel. volume Open Argus

Details

News Market Reaction – SNDX

On Apr 24, the day this news came out, SNDX closed 1.86% above the previous close.

Data tracked by StockTitan Argus for the Apr 24 session.

Key Figures

Earnings date: April 30, 2026 Call time: 4:30 p.m. ET Domestic dial-in: 800-590-8290 +5 more

Earnings date

April 30, 2026

Scheduled Q1 2026 financial results release

Call time

4:30 p.m. ET

Start time for Q1 2026 conference call and webcast

Domestic dial-in

800-590-8290

US access number for Q1 2026 earnings call

International dial-in

240-690-8800

International access number for Q1 2026 earnings call

Conference ID

Syndax1Q26

Identifier for Q1 2026 conference call

Replay availability

24 hours after

Replay posted ~24 hours after call on company website

Replay duration

90 days

Replay accessible for 90 days following the call

Price vs 52-week range

$21.00

Below 52-week high $25.59, above 52-week low $8.58 pre-announcement

Previous Conferences,earnings date Reports

1 past event · Latest: Feb 19

Same Type 1 event

1. Feb 19

   Earnings date notice

   24h Move

   +1.9%

   Announced Q4 and FY2025 results date and associated conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, April 30, 2026.

In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, April 30, 2026.

The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the following:

Conference ID: Syndax1Q26
Domestic Dial-in Number: 800-590-8290
International Dial-in Number: 240-690-8800
Live webcast: https://sndx-1q26.open-exchange.net

For those unable to participate in the conference call or webcast, a replay will be available on the Investors section of the Company's website at www.syndax.com approximately 24 hours after the conference call and will be available for 90 days following the call.

About Syndax

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X and LinkedIn.

Syndax Contact

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Syndax (SNDX) report first quarter 2026 financial results?

Syndax will report Q1 2026 financial results on Thursday, April 30, 2026, with a 4:30 p.m. ET webcast. According to the company, management will provide a business update alongside the earnings release and host a conference call and live audio webcast.

How can investors join the Syndax (SNDX) April 30, 2026 conference call or webcast?

Investors can join via the live webcast or by phone using the provided dial-in numbers and conference ID. According to the company, domestic dial-in is 800-590-8290, international dial-in is 240-690-8800, and the webcast is available at the posted open-exchange link.

Where will the Syndax (SNDX) conference call replay be available and for how long?

A replay will be available on the company's investor website about 24 hours after the conference call and will remain accessible for 90 days. According to the company, the replay will be posted in the Investors section at www.syndax.com.

What will Syndax (SNDX) management cover during the April 30, 2026 call?

Management will discuss first quarter 2026 financial results and provide a business update during the conference call and webcast. According to the company, presenters will use accompanying slides available on the Investors Events & Presentations page during the live audio webcast.